Join BJS Academy
BJS Academy>Randomized clinical ...>Piperacillin tazobac...
Normal View Dyslexic View

Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy. A randomized clinical trial.

19 July 2023
Randomized clinical trials HPB
D’Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gonen M, Thompson VM et al.

JAMA 2023; 329: 1579-1588.

The trial was stopped after interim analysis of 778 procedures. The combination of piperacillin and tazobactam reduced the risk of surgical site infection at 30 days: 19.8 versus 32.8 per cent, P<0.001. It also reduced the rate of relevant postoperative pancreatic fistula: 12.7 versus 19 per cent, P=0.03.

Comment: Promising new combination for open pancreatic surgery.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct100
Randomized clinical trials
Randomized clinical trials
HPB
Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy. A randomized clinical trial.
D’Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gonen M, Thompson VM et al.
19072023
JAMA 2023; 329: 1579-1588.
The trial was stopped after interim analysis of 778 procedures. The combination of piperacillin and tazobactam reduced the risk of surgical site infection at 30 days: 19.8 versus 32.8 per cent, P<0.001. It also reduced the rate of relevant postoperative pancreatic fistula: 12.7 versus 19 per cent, P=0.03.
Comment: Promising new combination for open pancreatic surgery.
Published on: 19 July 2023
Article ID: rct100

Related articles

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!